146 related articles for article (PubMed ID: 37343993)
1. Changes in cancer screening process in primary care during the covid-19 pandemic.
Atadağ YB; Türkmen AT; Öksüz A; Keten HS; Aydin MR
Saudi Med J; 2023 Jun; 44(6):621-624. PubMed ID: 37343993
[TBL] [Abstract][Full Text] [Related]
2. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
Su CH; Hsu PS; Lin CS
BMC Health Serv Res; 2023 Aug; 23(1):878. PubMed ID: 37605162
[TBL] [Abstract][Full Text] [Related]
4. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
5. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
Elife; 2023 Mar; 12():. PubMed ID: 36943035
[TBL] [Abstract][Full Text] [Related]
7. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic.
Rolle LD; Chery MJ; Larson M; Lopez-Pentecost M; Calfa CJ; Schlumbrecht MP; Crane TE
Prev Chronic Dis; 2024 Jan; 21():E05. PubMed ID: 38271492
[TBL] [Abstract][Full Text] [Related]
9. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
[TBL] [Abstract][Full Text] [Related]
10. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
[TBL] [Abstract][Full Text] [Related]
11. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
[TBL] [Abstract][Full Text] [Related]
12. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
13. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Whitmer A; Michel A; McIntyre M; Rossi SL; Kajtezovic S; Vadaparampil ST; Perkins R
Elife; 2023 Sep; 12():. PubMed ID: 37664989
[TBL] [Abstract][Full Text] [Related]
14. Changes in cancer screening before and during COVID-19: findings from the Korean National Cancer Screening Survey 2019 and 2020.
Trinh TTK; Lee YY; Suh M; Jun JK; Choi KS
Epidemiol Health; 2022; 44():e2022051. PubMed ID: 35638224
[TBL] [Abstract][Full Text] [Related]
15. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
17. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
[TBL] [Abstract][Full Text] [Related]
18. Impact of COVID-19 on Primary Care Quality Measures in an Academic Integrated Health System.
Kim E; Kojima N; Vangala S; Dermenchyan A; Lambrechts S; Grossman M; Han M; Croymans DM
J Gen Intern Med; 2022 Apr; 37(5):1161-1168. PubMed ID: 35083647
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
Chung A; Chen Q; Curry W; Felix T; Tuan WJ
Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
[TBL] [Abstract][Full Text] [Related]
20. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
